Published in Br J Haematol on December 01, 1997
scFv antibody: principles and clinical application. Clin Dev Immunol (2012) 1.64
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. Blood (2001) 4.76
The folding of hen lysozyme involves partially structured intermediates and multiple pathways. Nature (1992) 4.32
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
A gamma-ray burst at a redshift of z approximately 8.2. Nature (2009) 3.29
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia (2007) 2.76
Acute aluminum phosphide poisoning--an epidemiological, clinical and histo-pathological study. J Assoc Physicians India (1988) 2.71
An objective assessment of safety to drive in an upper limb cast. J Hand Surg Eur Vol (2012) 2.62
The Scottish doctor--learning outcomes for the medical undergraduate in Scotland: a foundation for competent and reflective practitioners. Med Teach (2002) 2.43
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
Broadband observations of the naked-eye gamma-ray burst GRB 080319B. Nature (2008) 2.16
Relativistic jet activity from the tidal disruption of a star by a massive black hole. Nature (2011) 2.12
Characterization of a partly folded protein by NMR methods: studies on the molten globule state of guinea pig alpha-lactalbumin. Biochemistry (1989) 2.11
Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J Virol (1999) 2.09
Serum free light chains for monitoring multiple myeloma. Br J Haematol (2004) 2.07
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood (2000) 1.93
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.88
Understanding how proteins fold: the lysozyme story so far. Trends Biochem Sci (1994) 1.83
A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus (1992) 1.79
Hydrogen exchange in native and denatured states of hen egg-white lysozyme. Proteins (1992) 1.79
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. Leukemia (2011) 1.77
Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.72
Kawasaki disease in Canterbury. Arch Dis Child (1978) 1.70
Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia (2006) 1.69
Concordance between clinician and patient assessment of physical and mental health status. J Rheumatol (1992) 1.53
32P-incorporation PCR for the detection of rearrangements at the TCR-gamma locus. Diagn Mol Pathol (1996) 1.52
Structure and dynamics of the acid-denatured molten globule state of alpha-lactalbumin: a two-dimensional NMR study. Biochemistry (1993) 1.52
Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J (1993) 1.49
Computed tomography of the head by the accident and emergency department--why 24 hour access is vital. J Accid Emerg Med (1998) 1.46
Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. Br J Haematol (1997) 1.45
Autoimmune thrombocytopenia in Waldenström's macroglobulinemia. Am J Hematol (2001) 1.42
Two cases of nabumetone induced pseudoporphyria. J Rheumatol (1999) 1.42
Dissecting the structure of a partially folded protein. Circular dichroism and nuclear magnetic resonance studies of peptides from ubiquitin. J Mol Biol (1993) 1.39
Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci U S A (2001) 1.39
Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim). Br J Haematol (1996) 1.39
Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res (1999) 1.39
Continual audit of clinical diagnostic accuracy by computer: a study of 592 autopsy cases. J Pathol (1987) 1.39
Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF. Bone Marrow Transplant (1998) 1.39
Fermi observations of high-energy gamma-ray emission from GRB 080916C. Science (2009) 1.37
Proline isomerism in staphylococcal nuclease characterized by NMR and site-directed mutagenesis. Nature (1987) 1.37
Early physiologic predictors of injury severity and death in blunt multiple trauma. Arch Surg (1990) 1.36
Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma. Leukemia (2005) 1.35
Tertiary interactions in the folding pathway of hen lysozyme: kinetic studies using fluorescent probes. Biochemistry (1994) 1.33
Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms. Br J Cancer (2005) 1.33
Karyotype and age in acute myeloid leukemia. Are they linked? Cancer Genet Cytogenet (2001) 1.32
Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet (1999) 1.27
Hospitalized incidence and case fatality for upper gastrointestinal bleeding from 1999 to 2007: a record linkage study. Aliment Pharmacol Ther (2011) 1.27
Multiple conformations of a protein demonstrated by magnetization transfer NMR spectroscopy. Nature (1986) 1.27
Systemic lupus erythematosus presenting with cardiac tamponade due to a haemorrhagic pericardial effusion. Postgrad Med J (1987) 1.25
Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. Immunity (2003) 1.24
Global analysis of the effects of temperature and denaturant on the folding and unfolding kinetics of the N-terminal domain of the protein L9. J Mol Biol (1998) 1.24
Kinetics of interaction of partially folded proteins with a hydrophobic dye: evidence that molten globule character is maximal in early folding intermediates. Protein Sci (1995) 1.23
Structure and stability of the molten globule state of guinea-pig alpha-lactalbumin: a hydrogen exchange study. Biochemistry (1993) 1.22
Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma. Leukemia (2010) 1.19
Chronic low back pain: comparison of bone SPECT with radiography and CT. Radiology (1992) 1.18
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement. Leukemia (2011) 1.17
Hypothenar hammer syndrome: an occupational cause of Raynaud's phenomenon. J Rheumatol (1987) 1.17
The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors. Aliment Pharmacol Ther (2013) 1.15
Structural characterization of a mutant peptide derived from ubiquitin: implications for protein folding. Protein Sci (2000) 1.14
Improved antimicrobial interventions have benefits. J Clin Microbiol (2001) 1.14
Tuberculosis risk among staff of a large public hospital in Kenya. Int J Tuberc Lung Dis (2008) 1.11
Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood (1991) 1.11
Waldenström macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors. Am J Clin Pathol (2001) 1.11
Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination. J Med Genet (2002) 1.11
Structure of very early protein folding intermediates: new insights through a variant of hydrogen exchange labelling. Fold Des (1996) 1.09
In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression. Br J Haematol (2001) 1.09
A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma. Leukemia (2007) 1.05
Criteria for the definition of Epstein-Barr virus association in Hodgkin's disease. Leukemia (1992) 1.01
The formalin test: a validation of the weighted-scores method of behavioural pain rating. Pain (1993) 1.00
Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse. Blood (2000) 1.00
An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. J Thromb Haemost (2008) 1.00
Autonomous folding of a peptide corresponding to the N-terminal beta-hairpin from ubiquitin. Protein Sci (1999) 0.99
Haplotype uncertainty in association studies. Genet Epidemiol (2007) 0.98
The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain. Oncogene (1995) 0.98
A peptide model for proline isomerism in the unfolded state of staphylococcal nuclease. J Mol Biol (1992) 0.98
FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells. Br J Haematol (1999) 0.97
An examination of the accident and emergency management of deliberate self harm. J Accid Emerg Med (1997) 0.96
Characterization of the pre-mRNA binding site for yeast ribosomal protein L32: the importance of a purine-rich internal loop. J Mol Biol (1995) 0.96
The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells. Blood (2000) 0.95
The significance of B-cell clonality in gastric lymphoid infiltrates. J Pathol (1996) 0.95
Lymphocytic gastritis, gastric adenocarcinoma, and primary gastric lymphoma. J Clin Pathol (1994) 0.94
High-resolution genomic profiling in hairy cell leukemia-variant compared with typical hairy cell leukemia. Leukemia (2011) 0.94
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation. Cytotherapy (2001) 0.93
European Concerted Action on Anticoagulation (ECAA): multicentre international sensitivity index calibration of two types of point-of-care prothrombin time monitor systems. Br J Haematol (2002) 0.93
High dose DBMC associated tolerance in live-related renal allograft recipients. Transplant Proc (2000) 0.93
Conserved structural features on protein surfaces: small exterior hydrophobic clusters. J Mol Biol (1995) 0.93